Lypressin

This classification denotes an antidiurectic hormone analogue with the molecular formula C46H65N13O12S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7CZF3L922Y, chemically known as vasopressin, 8-l-lysine- but generally known as lypressin, which bears US NIH Compound Identifier 5772. European Medicines Agency schedules Lypressin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08627MIG. The term LYPRESSIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules lypressin in its Anatomical Therapeutic Chemical (ATC) Classification. LYPRESSIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lypressin under HS 29371900 and SITC 54154. As of Q4 2014, LYPRESSIN remains the US FDA Preferred Term for this commodity. Lypressin bears US NLM identifiers UMLS ID C0024328 and NCI Concept Code C66044. SMILES: S1SCC(N)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2C(CCC2)C(=O)NC(CCCCN)C(=O)NCC(=O)N)C1)CC(=O)N)CCC(=O)N)CC1CCCCC1)CC1CCC(O)CC1.